Breaking News Instant updates and real-time market news.

EADSY

Airbus

$0.00 /

+ (+0.00%)

06:13
09/11/19
09/11
06:13
09/11/19
06:13

Airbus orders checks on 3 helicopter models following Norway crash, Reuters says

Airbus Helicopters has issued an emergency alert service bulletin following a helicopter crash in Arctic Norway on August 31, calling for visual inspections of this area on all recently delivered AS350, AS550 and EC130 helicopters, Reuters' Gwladys Fouche and Terje Solsvik report. "According to Airbus Helicopters, issuance of the EASB is a precautionary measure to ensure the continued airworthiness of the helicopter type," the Accident Investigation Board Norway said in a statement. The crashed aircraft had flown just 73 hours, it added. Reference Link

EADSY Airbus
$0.00 /

+ (+0.00%)

05/08/19 Goldman Sachs
Airbus upgraded to Neutral from Sell at Goldman Sachs
03/13/19 Loop Capital
Hexcel may not benefit from aircraft order shift to Airbus, says Loop Capital
10/23/18 Credit Suisse
Airbus upgraded to Outperform from Neutral at Credit Suisse
10/23/18 Credit Suisse
Airbus upgraded to Outperform from Neutral at Credit Suisse

TODAY'S FREE FLY STORIES

Recommendations
Installed Building Products price target raised to $104 from $87 at Benchmark » 06:50
08/10/20
08/10
06:50
08/10/20
06:50
IBP

Installed Building Products

$85.92 /

+0.82 (+0.96%)

Benchmark analyst Reuben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

08/07/20 Zelman
Installed Building Products upgraded to Buy from Hold at Zelman
07/16/20 BTIG
Installed Building Products, Builders FirstSource price targets raised at BTIG
07/08/20 SunTrust
SunTrust ups Installed Building Products, TopBuild, Builders FirstSource targets
06/18/20 Benchmark
Installed Building Products price target raised to $87 from $63 at Benchmark
IBP Installed Building Products
$85.92 /

+0.82 (+0.96%)

Earnings
Zynerba reports Q2 EPS (78c), consensus (45c) » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
ZYNE

Zynerba

$4.20 /

-0.08 (-1.87%)

As of June 30 cash and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

07/01/20 H.C. Wainwright
Zynerba market cap 'greatly underprices' potential, says H.C. Wainwright
07/01/20 Canaccord
Zynerba price target lowered to $12 from $18 at Canaccord
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
07/01/20 Needham
Zynerba downgraded to Hold from Buy at Needham
ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

ZYNE Zynerba
$4.20 /

-0.08 (-1.87%)

Hot Stocks
Reata Pharmaceuticals says pre-NDA meeting granted for Bardoxolone » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
RETA

Reata Pharmaceuticals

$157.16 /

+5.07 (+3.33%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
05/18/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $275 from $270 at Cantor Fitzgerald
04/17/20 Jefferies
Reata Pharmaceuticals price target raised to $348 from $335 at Jefferies
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

Upgrade
CF Industries upgraded to Buy from Neutral at Citi » 06:49
08/10/20
08/10
06:49
08/10/20
06:49
CF

CF Industries

$33.13 /

-0.26 (-0.78%)

Citi analyst P.J. Juvekar…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

08/07/20
Fly Intel: Top five analyst upgrades
08/07/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
08/07/20 Citi
CF Industries upgraded to Buy from Neutral at Citi
07/13/20
Fly Intel: Top five analyst upgrades
CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

CF CF Industries
$33.13 /

-0.26 (-0.78%)

Initiation
GoHealth initiated with an Outperform at RBC Capital » 06:48
08/10/20
08/10
06:48
08/10/20
06:48
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

RBC Capital analyst Frank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
06:22 Today Truist
GoHealth initiated with a Buy at Truist
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Reata Pharmaceuticals reports Q2 adjusted EPS ($1.23), consensus ($2.84) » 06:47
08/10/20
08/10
06:47
08/10/20
06:47
RETA

Reata Pharmaceuticals

$157.16 /

+5.07 (+3.33%)

Reports Q2 collaboration…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

07/10/20 Stifel
Reata transferred with Buy rating, removed from Select List at Stifel
06/16/20 BTIG
Reata Pharmaceuticals initiated with a Buy at BTIG
05/18/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $275 from $270 at Cantor Fitzgerald
04/17/20 Jefferies
Reata Pharmaceuticals price target raised to $348 from $335 at Jefferies
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

  • 14
    Nov
RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

RETA Reata Pharmaceuticals
$157.16 /

+5.07 (+3.33%)

Earnings
Target Hospitality reports Q2 EPS (15c), consensus (11c) » 06:46
08/10/20
08/10
06:46
08/10/20
06:46
TH

Target Hospitality

$1.45 /

-0.04 (-2.68%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$1.45 /

-0.04 (-2.68%)

TH Target Hospitality
$1.45 /

-0.04 (-2.68%)

04/01/20 Northland
Northland downgrades Target Hospitality on oil market deterioration
04/01/20 Northland
Target Hospitality downgraded to Market Perform from Outperform at Northland
03/10/20 Stifel
Target Hospitality downgraded to Hold from Buy at Stifel
02/28/20 Deutsche Bank
Target Hospitality downgraded to Hold from Buy at Deutsche Bank
TH Target Hospitality
$1.45 /

-0.04 (-2.68%)

Downgrade
Rayonier downgraded to Neutral from Buy at Citi » 06:46
08/10/20
08/10
06:46
08/10/20
06:46
RYN

Rayonier

$28.10 /

-0.205 (-0.72%)

Citi analyst Anthony…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RYN Rayonier
$28.10 /

-0.205 (-0.72%)

RYN Rayonier
$28.10 /

-0.205 (-0.72%)

03/27/20 Citi
Rayonier upgraded to Buy from Neutral at Citi
01/07/20 Raymond James
Timber REIT sector upgraded to Overweight from Market Weight at Raymond James
11/01/19 DA Davidson
Rayonier upgraded to Buy from Neutral at DA Davidson
11/01/19 DA Davidson
Rayonier upgraded to Buy from Neutral at DA Davidson
RYN Rayonier
$28.10 /

-0.205 (-0.72%)

Initiation
GoHealth initiated with an Overweight at Cantor Fitzgerald » 06:45
08/10/20
08/10
06:45
08/10/20
06:45
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

Cantor Fitzgerald analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

06:24 Today Goldman Sachs
GoHealth initiated with a Buy at Goldman Sachs
06:24 Today BofA
GoHealth initiated with a Buy at BofA
06:22 Today Truist
GoHealth initiated with a Buy at Truist
06:08 Today Barclays
GoHealth initiated with an Overweight at Barclays
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Upgrade
TopBuild upgraded to Buy from Neutral at BTIG » 06:45
08/10/20
08/10
06:45
08/10/20
06:45
BLD

TopBuild

$141.82 /

+2.61 (+1.87%)

BTIG analyst Ryan Gilbert…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BLD TopBuild
$141.82 /

+2.61 (+1.87%)

BLD TopBuild
$141.82 /

+2.61 (+1.87%)

06:37 Today Stephens
TopBuild price target raised to $150 from $100 at Stephens
06:33 Today BTIG
TopBuild upgraded to Buy from Neutral at BTIG
08/05/20 Credit Suisse
TopBuild price target raised to $176 from $149 at Credit Suisse
08/05/20 Deutsche Bank
TopBuild price target raised to $160 from $130 at Deutsche Bank
BLD TopBuild
$141.82 /

+2.61 (+1.87%)

General news
FX Update: The dollar has traded moderately firmer » 06:45
08/10/20
08/10
06:45
08/10/20
06:45

FX Update: The dollar has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
OraSure initiated with a Buy at Citi » 06:44
08/10/20
08/10
06:44
08/10/20
06:44
OSUR

OraSure

$14.04 /

+0.95 (+7.26%)

Citi analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OSUR OraSure
$14.04 /

+0.95 (+7.26%)

OSUR OraSure
$14.04 /

+0.95 (+7.26%)

06:11 Today JPMorgan
OraSure initiated with a Neutral at JPMorgan
08/07/20 Raymond James
OraSure upgraded to Outperform from Market Perform at Raymond James
08/07/20 Raymond James
OraSure upgraded to Outperform from Market Perform at Raymond James
06/25/20 Lake Street
OraSure initiated with a Buy at Lake Street
OSUR OraSure
$14.04 /

+0.95 (+7.26%)

  • 03
    Jun
OSUR OraSure
$14.04 /

+0.95 (+7.26%)

Recommendations
Waste Connections price target raised to $115 from $110 at Stifel » 06:42
08/10/20
08/10
06:42
08/10/20
06:42
WCN

Waste Connections

$101.85 /

-1.36 (-1.32%)

Stifel analyst Michael…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

08/07/20 UBS
Waste Connections price target raised to $116 from $108 at UBS
07/20/20 KeyBanc
Waste Connections price target raised to $115 from $105 at KeyBanc
07/10/20 BMO Capital
Waste Connections price target raised to $106 from $104 at BMO Capital
07/01/20 Jefferies
GFL Environmental initiated with a Buy at Jefferies
WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

WCN Waste Connections
$101.85 /

-1.36 (-1.32%)

Hot Stocks
LogicBio Therapeutics announces clinical trial design for LB-001 » 06:41
08/10/20
08/10
06:41
08/10/20
06:41
LOGC

LogicBio Therapeutics

$7.88 /

+0.13 (+1.68%)

LogicBio Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

01/10/20 Roth Capital
LogicBio reported 'two wins' with updates, says Roth Capital
LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

Hot Stocks
Seres Therapeutics soars 170% after 'positive' results from Phase 3 ECOSPOR III » 06:41
08/10/20
08/10
06:41
08/10/20
06:41
MCRB

Seres Therapeutics

$4.65 /

+0.22 (+4.97%)

In pre-market trading,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MCRB Seres Therapeutics
$4.65 /

+0.22 (+4.97%)

MCRB Seres Therapeutics
$4.65 /

+0.22 (+4.97%)

Recommendations
TripAdvisor price target raised to $21 from $15 at Stifel » 06:41
08/10/20
08/10
06:41
08/10/20
06:41
TRIP

TripAdvisor

$21.07 /

-0.55 (-2.54%)

Stifel analyst Logan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

07/29/20 Jefferies
Booking Holdings price target raised to $1,600 from $1,300 at Jefferies
06/23/20 RBC Capital
TripAdvisor's Q2 update implies sequential improvement, says RBC Capital
06/10/20 BTIG
TripAdvisor initiated with a Neutral at BTIG
05/11/20 Credit Suisse
TripAdvisor price target lowered to $22 from $28 at Credit Suisse
TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

TRIP TripAdvisor
$21.07 /

-0.55 (-2.54%)

Upgrade
Fidus Investment upgraded to Buy from Neutral at Ladenburg » 06:39
08/10/20
08/10
06:39
08/10/20
06:39
FDUS

Fidus Investment

$10.25 /

+1.42 (+16.08%)

Ladenburg analyst Mickey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDUS Fidus Investment
$10.25 /

+1.42 (+16.08%)

FDUS Fidus Investment
$10.25 /

+1.42 (+16.08%)

03/24/20 B. Riley FBR
Fidus Investment downgraded to Neutral from Buy at B. Riley FBR
03/17/20 National Securities
Fidus Investment upgraded to Buy from Neutral at National Securities
10/23/19 National Securities
Fidus Investment initiated with a Neutral at National Securities
10/11/19 Raymond James
Fidus Investment downgraded to Outperform, target cut to $16 at Raymond James
FDUS Fidus Investment
$10.25 /

+1.42 (+16.08%)

Initiation
MorphoSys initiated with a Buy at Citi » 06:39
08/10/20
08/10
06:39
08/10/20
06:39
MOR

MorphoSys

/

+

Citi analyst Vineet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MOR MorphoSys
/

+

MOR MorphoSys
/

+

08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
06/25/20 RBC Capital
MorphoSys downgraded to Sector Perform from Outperform at RBC Capital
05/13/20 Barclays
MorphoSys price target raised to EUR 105 from EUR 100 at Barclays
MOR MorphoSys
/

+

MOR MorphoSys
/

+

MOR MorphoSys
/

+

Hot Stocks
InspireMD regains NYSE American compliance » 06:38
08/10/20
08/10
06:38
08/10/20
06:38
NSPR

InspireMD

$0.46 /

+0.0069 (+1.52%)

InspireMD announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NSPR InspireMD
$0.46 /

+0.0069 (+1.52%)

NSPR InspireMD
$0.46 /

+0.0069 (+1.52%)

Initiation
Hub Group initiated with an In Line at Evercore ISI » 06:38
08/10/20
08/10
06:38
08/10/20
06:38
HUBG

Hub Group

$54.63 /

+1.39 (+2.61%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HUBG Hub Group
$54.63 /

+1.39 (+2.61%)

HUBG Hub Group
$54.63 /

+1.39 (+2.61%)

07/15/20 Barclays
Hub Group price target raised to $45 from $41 at Barclays
07/09/20 JPMorgan
Hub downgraded to Neutral on slower recovery risk at JPMorgan
07/09/20 Stephens
Hub Group price target raised ahead of expected earnings beat at Stephens
07/09/20 JPMorgan
Hub Group downgraded to Neutral from Overweight at JPMorgan
HUBG Hub Group
$54.63 /

+1.39 (+2.61%)

Initiation
J.B. Hunt initiated with an Outperform at Evercore ISI » 06:38
08/10/20
08/10
06:38
08/10/20
06:38
JBHT

J.B. Hunt

$135.93 /

+2.085 (+1.56%)

Evercore ISI analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBHT J.B. Hunt
$135.93 /

+2.085 (+1.56%)

JBHT J.B. Hunt
$135.93 /

+2.085 (+1.56%)

07/20/20 Argus
J.B. Hunt price target raised to $155 from $115 at Argus
07/17/20
Fly Intel: Top five analyst upgrades
07/17/20 BMO Capital
J.B. Hunt price target raised to $125 from $100 at BMO Capital
07/17/20 Baird
J.B. Hunt price target raised to $148 from $128 at Baird
JBHT J.B. Hunt
$135.93 /

+2.085 (+1.56%)

JBHT J.B. Hunt
$135.93 /

+2.085 (+1.56%)

JBHT J.B. Hunt
$135.93 /

+2.085 (+1.56%)

Earnings
LogicBio Therapeutics reports Q2 EPS (35c), consensus (48c) » 06:38
08/10/20
08/10
06:38
08/10/20
06:38
LOGC

LogicBio Therapeutics

$7.88 /

+0.13 (+1.68%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

01/10/20 Roth Capital
LogicBio reported 'two wins' with updates, says Roth Capital
LOGC LogicBio Therapeutics
$7.88 /

+0.13 (+1.68%)

Hot Stocks
Trevena announces FDA approval of OLINVYK injection » 06:38
08/10/20
08/10
06:38
08/10/20
06:38
TRVN

Trevena

$2.36 /

-0.06 (-2.48%)

Trevena announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRVN Trevena
$2.36 /

-0.06 (-2.48%)

TRVN Trevena
$2.36 /

-0.06 (-2.48%)

09/03/19 H.C. Wainwright
Trevena's oliceridine 'close to the finish line,' says H.C. Wainwright
TRVN Trevena
$2.36 /

-0.06 (-2.48%)

TRVN Trevena
$2.36 /

-0.06 (-2.48%)

Hot Stocks
Pieris Pharmaceuticals, Eli Lilly enter clinical trial collaboration » 06:37
08/10/20
08/10
06:37
08/10/20
06:37
PIRS

Pieris Pharmaceuticals

$2.68 /

-0.06 (-2.19%)

, LLY

Eli Lilly

$152.89 /

+0.01 (+0.01%)

Pieris Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

03/13/20 Baird
Baird upgrades Pieris Pharmaceuticals as pipeline updates expected
03/13/20 Baird
Pieris Pharmaceuticals upgraded to Outperform from Neutral at Baird
03/12/20 H.C. Wainwright
Increased visibility in 2020 expected for Pieris, says H.C. Wainwright
01/27/20 H.C. Wainwright
Pieris Pharmaceuticals price target raised to $9 from $7 at H.C. Wainwright
LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

07/31/20 Barclays
Eli Lilly earnings selloff 'meaningful over-reaction,' says Barclays
07/15/20 H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

PIRS Pieris Pharmaceuticals
$2.68 /

-0.06 (-2.19%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

LLY Eli Lilly
$152.89 /

+0.01 (+0.01%)

Recommendations
TopBuild price target raised to $150 from $100 at Stephens » 06:37
08/10/20
08/10
06:37
08/10/20
06:37
BLD

TopBuild

$141.82 /

+2.61 (+1.87%)

Stephens analyst Trey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLD TopBuild
$141.82 /

+2.61 (+1.87%)

BLD TopBuild
$141.82 /

+2.61 (+1.87%)

06:33 Today BTIG
TopBuild upgraded to Buy from Neutral at BTIG
08/05/20 Credit Suisse
TopBuild price target raised to $176 from $149 at Credit Suisse
08/05/20 Deutsche Bank
TopBuild price target raised to $160 from $130 at Deutsche Bank
07/08/20 SunTrust
SunTrust ups Installed Building Products, TopBuild, Builders FirstSource targets
BLD TopBuild
$141.82 /

+2.61 (+1.87%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.